MedPath

To study the effect of ayurvedic formulation in hyper lipidima

Phase 2
Conditions
Health Condition 1: E784- Other hyperlipidemia
Registration Number
CTRI/2024/08/072604
Lead Sponsor
Dr Shraddha Shankar Wavare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of age group 21-60 irrespective of their gende2.Patients of medoroga as per signs and symptoms mention in Ayurvedic samhita and hyperlipidemia condition.3. the patient who has in between values of either 1. serum cholesterol 200-240 mg dl or 2.serum triglycerides 150-400 mg dl

Exclusion Criteria

1.Pregnant women or lactating mother

2. Acute life threatening conditions like cancer and post MI

3. Obesity due to other conditions like endocrinal diseases

4. Patients diagnosed with diabetes mellitus type 2,

immunological diseases and hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To decrease the kshudrashwas, Daurbalya,Sarvkriya Asamartha, Alpapran,Atinidra,Kshudha atiyoga,Pipasa atiyog mentioned in ayurvedaTimepoint: 90 days study with follow up on 30th,60th,90th day
Secondary Outcome Measures
NameTimeMethod
To study the effect on1Serum Cholesterol <br/ ><br>2.Serum Triglyceride <br/ ><br>3.HDL <br/ ><br>4.LDL in MedorogaTimepoint: 90 days study with follow up on 30th, 60th, 90th day (0,30,60,90)
© Copyright 2025. All Rights Reserved by MedPath